These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11439320)

  • 1. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy.
    Khong TK; Missouris CG; Belli AM; MacGregor GA
    J Hum Hypertens; 2001 Jun; 15(6):431-3. PubMed ID: 11439320
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerotic renal artery stenosis: there is no obvious reason to dilate.
    Golan E
    Isr Med Assoc J; 2004 Nov; 6(11):710-2. PubMed ID: 15562818
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid lowering therapy and stabilization of atherosclerotic plaques.
    Krone W; Müller-Wieland D
    Thromb Haemost; 1999 Sep; 82 Suppl 1():60-1. PubMed ID: 10695487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial.
    Marcantoni C; Zanoli L; Rastelli S; Tripepi G; Matalone M; Di Landro D; Scandura S; Tamburino C; Zoccali C; Castellino P
    J Nephrol; 2009; 22(1):13-6. PubMed ID: 19229814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in renal atherosclerotic disease.
    Udani SM; Dieter RS
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):873-81. PubMed ID: 18570624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renovascular hypertension: diagnostic and therapeutic challenges.
    Bosmans JL; De Broe ME
    JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.
    Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Chaplin WF; Muntwyler J; Viles-Gonzalez JF; Weinberger J; Smith DA; Mizsei G; Badimon JJ
    J Am Coll Cardiol; 2005 Jul; 46(1):106-12. PubMed ID: 15992643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting long-term survival following renal artery stenting.
    Bates MC; Campbell JE; Stone PA; Jaff MR; Broce M; Lavigne PS
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1037-43. PubMed ID: 17525962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is survival of patients with atherosclerotic renal artery stenosis affected by different predictors compared to other atherosclerosis manifestations?
    Zeller T
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1046-7. PubMed ID: 17525963
    [No Abstract]   [Full Text] [Related]  

  • 10. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Med; 2005 Dec; 118 Suppl 12A():22-7. PubMed ID: 16356804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management.
    Plouin PF
    Am J Kidney Dis; 2003 Nov; 42(5):851-7. PubMed ID: 14582030
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive lipid lowering therapy and atherosclerosis.
    Jain P; Misra A
    Natl Med J India; 1992; 5(1):20-1. PubMed ID: 1304240
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood lipid derangement common in peripheral artery disease. Lipid-lowering agents may alleviate symptoms and slow the atherosclerotic process].
    Bröijersén A; Wiklund B; Angelin B
    Lakartidningen; 2001 Sep; 98(36):3788-93. PubMed ID: 11586809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-altering therapies and the progression of atherosclerotic disease.
    Wierzbicki AS
    Cardiovasc Intervent Radiol; 2007; 30(2):155-60. PubMed ID: 17206389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic plaque imaging and monitoring atherosclerotic plaque interventions.
    Momiyama Y; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):349-55. PubMed ID: 18025989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention?
    Krijnen P; van Jaarsveld BC; Deinum J; Steyerberg EW; Habbema JD
    J Hum Hypertens; 2004 Feb; 18(2):91-6. PubMed ID: 14730323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive lipid-lowering therapy for patients with aortic stenosis.
    Pedersen TR
    Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Letter: Lipid lowering drugs].
    Weizel A
    Dtsch Med Wochenschr; 1973 Dec; 98(50):2426. PubMed ID: 4764780
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regression of arteriosclerosis. Results of animal experiments and human medical studies, results of drug therapy].
    Kaffarnik H; Zehner J
    Fortschr Med; 1985 May; 103(20):531-4. PubMed ID: 4007752
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical versus surgical management of atherosclerotic renal artery stenosis.
    Uzzo RG; Novick AC; Goormastic M; Mascha E; Pohl M
    Transplant Proc; 2002 Mar; 34(2):723-5. PubMed ID: 12009679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.